Bruker

Bruker

BRKR
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

BRKR · Stock Price

USD 43.73+10.38 (+31.12%)
Market Cap: $6.5B

Historical price data

Market Cap: $6.5BFounded: 1960Employees: 7,000-8,000 (global estimate)HQ: Billerica, United States

Overview

Bruker's mission is to enable scientists to make breakthrough discoveries and develop new applications that improve the quality of human life through differentiated high-value life science research and diagnostics solutions. The company has achieved a premier position as a critical technology enabler, with flagship platforms like timsTOF mass spectrometry and ultra-high-field NMR driving the frontiers of proteomics and structural biology. Its strategy is built on deep technological innovation, a comprehensive service-oriented culture, and a business model that combines high-margin instrument sales with stable recurring revenue from consumables and services.

DiagnosticsProteomicsMedical Devices

Technology Platform

Bruker's technology platform is a diversified portfolio of proprietary, high-performance scientific instrumentation and integrated solutions spanning mass spectrometry, magnetic resonance, microscopy, and X-ray analysis, enabling breakthrough discoveries in life science research, applied markets, and diagnostics.

Funding History

3
Total raised:$500M
Debt$500M
IPOUndisclosed
IPOUndisclosed

Opportunities

Bruker is poised to capitalize on the explosive growth in proteomics and spatial biology driven by personalized medicine, the expansion of its high-margin recurring revenue streams from its large installed base, and the translation of its core technologies into robust applied markets like food safety and industrial QA/QC, which offer stable, non-cyclical growth.

Risk Factors

Key risks include cyclical sensitivity to capital expenditure budgets in academia and biopharma, intense competition from larger, broad-based players like Thermo Fisher and Danaher, execution risks in integrating acquisitions, and potential supply chain disruptions for complex instrument manufacturing.

Competitive Landscape

Bruker competes in specialized, high-performance niches against giants like Thermo Fisher Scientific and Danaher (via SCIEX, Leica), as well as focused players like Waters and Agilent. Its advantage lies not in breadth but in technological depth and best-in-class performance for specific applications such as next-gen proteomics (timsTOF) and ultra-high-field NMR, where it holds leadership positions.

Company Timeline

1960Founded

Founded in Billerica, United States

2000IPO

Initial Public Offering

2021Debt

Debt: $500.0M